Urgent action is required to address the shortage of dentists in Cork for children and those with special needs. The number of senior dental surgeons employed by the HSE in Cork and Kerry who provide ...

BUTLER COUNTY, Ohio — Many veterans struggle to access dental care that most people take for granted. A new program in Butler County is working to change that reality. On average, only one out of ...

"Screenshot of MeAgain GLP-1 tracking app." MeAgain Named the #1 GLP-1 Tracking App for Zepbound, Mounjaro, Wegovy & Ozempic Users in 2026. Comprehensive all-in-one platform outperforms five major ...

An emerging approach that uses aqueous chlorhexidine to prevent infections after intravitreal injections to deliver drugs into the eye is as effective as the long prevailing method that uses povidone ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...

Kilmeade made the comment Sept. 10, 2025, and it spread widely online on Sept. 13. Kilmeade apologized Sept. 14, calling his remark "extremely callous." In the context of the segment in which it was ...

BOSTON (WWLP) – A new bill in Massachusetts aims to allow dental hygienists to administer Botox and fillers, sparking a debate between dental professionals and dermatologists. The proposed legislation ...

The humble inventions that power our modern world wouldn’t have been possible without decades of support for early-stage research. In December 1947, three physicists at Bell Telephone ...

Leqembi (lecanemab-irmb) is a prescription medicine approved to treat early stages of Alzheimer's disease, such as mild cognitive impairment or mild dementia. The recent FDA approval of Leqembi IQLIK ...

Universal or guaranteed basic income programs are gaining momentum across the country, as local governments and nonprofits experiment with the bold new alternative to traditional welfare models.

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...